Anti-suicidal Effects of Buprenorphine in Opioid Use Disorder
Status:
Withdrawn
Trial end date:
2021-06-10
Target enrollment:
Participant gender:
Summary
The study aims to examine the effect of buprenorphine on suicidal ideation in individuals
with opioid use disorder, and to investigate the functional brain activity related to its
potential anti-suicidal effect.
Phase:
Phase 4
Details
Lead Sponsor:
New York State Psychiatric Institute
Treatments:
Buprenorphine Buprenorphine, Naloxone Drug Combination Morphine Naloxone